ArticleBMC women's health2025
Beyond infection status: a cross-sectional study of socioeconomic disparities, infection dynamics, and psychosocial burden among women with HPV in Luzhou, China.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV) infection entails oncologic risk as well as substantial psychosocial and quality-of-life (QoL) burden. data from Southwest China remain limited. This study aims to evaluate anxiety, depression, and quality of life among HPV-positive women in Luzhou, China.
methodsIn this cross-sectional study, 441 HPV-positive women attending two tertiary hospitals (November 2023–September 2024) completed the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and a culturally adapted HPV Impact Profile (HIP). Clinically relevant anxiety and depression were defined as GAD-7 or PHQ-9 ≥ 5 (mild or greater). Multivariate binary logistic regression identified predictors; HIP construct validity was examined using confirmatory factor analysis (CFA).
resultsThe prevalence of anxiety and depression symptoms among HPV-positive women was 40.36% and 41.72%, respectively. The HIP demonstrated excellent internal consistency (Cronbach’s α = 0.946) and acceptable fit (CFI 0.927; RMSEA 0.079). Quality of life analysis indicated the highest domain burden was Worry & Concern (66.73 ± 34.33). Lower monthly income emerged as a protective factor for both anxiety and depression. Key risk predictors for both anxiety and depression included HPV16/18 infection (OR = 3.11; OR = 2.76, respectively), shorter infection duration (OR = 5.77; OR = 7.24, respectively), and higher HIP domain scores (all p < 0.01). Reduced gravidity (≤ 1 pregnancy: OR = 2.832) and parity (≤ 1 birth: OR = 3.889; 2–3 births: OR = 3.056) were identified as specific risk factors for depression. Current smoking showed an inverse association with both anxiety and depression (OR = 0.350; OR = 0.324, respectively), though this requires cautious interpretation. Regression analyses further identified specific psychosocial domains, such as emotional impact and self-image, as significant predictors for these mental health conditions.
conclusionsSubstantial psychosocial and QoL burden accompanies HPV infection in Southwest China, concentrated in worry, emotional distress, body image, relational, and healthcare interaction domains. Early, genotype-informed, culturally adapted psychosocial screening and counseling are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.